89bio, Inc. (ETNB) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 818.87M |
| Enterprise Value | 730.36M |
| P/E Ratio | -12.37 |
| PEG Ratio | 0.21 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 4.49 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -11.59 |
Fiscal Year
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | June 30, 2025 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -0.3 |
| Return On Equity | -0.32 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -38,000 |
| EBITDA | -384.66M |
| Net Income | -367.08M |
| Diluted EPS | -3.51 |
Balance Sheet
| Total Cash | 561.16M |
| Total Cash/Share | 3.55 |
| Total Debt | 37.62M |
| Total Debt/Equity | 0.07 |
| Current Ratio | 15.19 |
| Book Value Per Share | 3.3 |
Price History
| 52-Week Change | 65.07 |
| 52-Week High | 15.06 |
| 52-Week Low | 4.16 |
| Moving Average 50 Days | 12.41 |
| Moving Average 200 Days | 9.75 |
Statistics
| Average Volume | 5.39M |
| Shares Outstanding | 148.3M |
| % Held by Institutions | 97.98 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
